Unlock instant, AI-driven research and patent intelligence for your innovation.

Artificial antigen presenting cell and preparation method and application thereof

An artificial antigen and cell technology, applied in biochemical equipment and methods, animal cells, vertebrate cells, etc., can solve the problems of complicated DC cell operation, difficulty in forming commercial products, and long culture cycle, etc., to achieve significant T cell expansion, Good biocompatibility, effect of increasing specific surface area

Active Publication Date: 2022-07-05
CANCER INST & HOSPITAL CHINESE ACADEMY OF MEDICAL SCI +1
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although DC cells have shown an important role in the activation of T cells, the operation of separating and inducing activated DC cells in vitro is complicated, the culture period is long, and the large-scale preparation of primary DC cells is difficult; in addition, the activation state of DC cells is unstable, resulting in stimulation of T cells. There are large differences in cell effects between batches; more importantly, DC cells will prevent excessive activation of T cells by expressing inhibitory signaling molecules. Due to the lack of control of this negative regulation, it will seriously affect the function of stimulating T cells and subsequent therapeutic effects (Steinman and Banchereau,2007), it is difficult to form commodity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Artificial antigen presenting cell and preparation method and application thereof
  • Artificial antigen presenting cell and preparation method and application thereof
  • Artificial antigen presenting cell and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0080] Example 1. Preparation of PLLA rough microspheres

[0081] 1) Contains Fe 3 O 4 Preparation of PLLA Rough Microspheres

[0082] A. Centrifuge at 8,000 rpm for 5 min, collect smooth microspheres prepared with different molecular weights of PLLA (Mw: 5000, 10000, 50000), and fully remove the water.

[0083] B. Add 5mL of tetrahydrofuran into the centrifuge tube, disperse evenly with a pipette, suspend at 25°C for 30min; centrifuge at 8,000rpm for 5min;

[0084] C. Repeat the above dissolving process twice; centrifuge at 8,000 rpm for 5 min, wash three times with deionized water, and characterize the morphology of the prepared microspheres.

[0085] The PLLA microspheres with molecular weights of 5,000 and 10,000 were completely dissolved by tetrahydrofuran, and the PLLA microspheres with molecular weights of 50,000 were partially dissolved and formed rough morphology with an average particle size of 10 μm. Therefore, the preparation of rough microspheres uses PLLA wit...

Embodiment 2

[0086] Example 2. Preparation of artificial antigen presenting cells

[0087] 1) Contains Fe 3 O 4 Preparation of PLLA Rough Microspheres:

[0088] A. Centrifuge at 8,000 rpm for 5 min to collect Fe-containing 3 O 4 PLLA smooth microspheres, which fully remove moisture.

[0089] B. Add 5mL of tetrahydrofuran into the centrifuge tube, disperse evenly with a pipette, suspend at 25°C for 30min; centrifuge at 8,000rpm for 5min;

[0090] C. Repeat the above dissolving process 2 times; centrifuge at 8,000 rpm for 5 min, wash 3 times with deionized water, and obtain Fe-containing 3 O 4 PLLA rough microspheres (c-MS) with an average particle size of 10 μm.

[0091] A smooth microsphere (s-MS) with a particle size of 2 μm internally distributed with ferric oxide was selected. Others were the same as in this example, and PLLA rough microspheres with holes on the surface, deeper surface roughness and an average particle size of 2 μm were prepared. .

[0092] 2) Physical adsorpti...

Embodiment 3

[0101] Example 3. aAPCs prepared from rough PLLA microspheres for T cell activation and expansion

[0102] 1) Use CD3 negative kit to separate T cells in the spleen of C57 / B6 mice;

[0103] 2) Mix aAPCs with mouse primary T cells according to the number ratio of 1:2, 1:10 and 1:20, in a mixture containing 10% FBS, 1% double antibody, 1% non-essential amino acids and IL2 (300U / mL) in RPMI1640 medium, 37°C, 5% CO 2 After culturing in the incubator for 5 days, the proliferation of T cells was detected by CCK-8 kit, and the level of IFN-γ secreted by T cell culture supernatant was detected by CBA method.

[0104] The example proves that the activation effect is the best when the ratio of aAPCs to mouse primary T cells is 1:2, and the final antibody concentration of aAPC and T cells is 200ng / mL when the final concentration of aAPC and T cells is co-cultured to stimulate the expansion and activation of T cells. Better than 40ng / mL and 1000ng / mL.

[0105] Rough microsphere morpho...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
concentrationaaaaaaaaaa
Login to View More

Abstract

The invention discloses an artificial antigen presenting cell and a preparation method and application thereof. The invention establishes a method for controlling the topological structure and appearance of the surface of the polymer microsphere, which can be used to stimulate the expansion and activation of immune cells to exert the antigen presentation function of the microsphere through signal molecule modification. The material used in the invention has biocompatibility and degradability, and the method for preparing the surface rough structure is easy to operate, environmentally friendly and has good reproducibility.

Description

technical field [0001] The invention belongs to the field of cell therapy and immunotherapy, and in particular relates to an artificial antigen presenting cell and a preparation method and application thereof. Background technique [0002] In recent years, T cell immunotherapy research has developed rapidly, especially the emergence of genetically engineered T cells has significantly improved the specificity and killing intensity of immunotherapy, and achieved great success for the first time in the treatment of acute B lymphocytic leukemia (Brentjens et al., 2011). Up to now, a large number of clinical trials of genetically modified T-cell immunotherapy have been carried out in a variety of malignant tumors, making T-cell immunotherapy the most valuable and promising new anti-tumor therapy (Johnson and June, 2017). In order to obtain sufficient T cells, autologous DC cells have been used to stimulate and expand T cells in vitro (Wang et al., 2014). Although DC cells play ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K47/69A61K39/395A61K47/02A61K47/59A61K47/66A61P35/00A61P37/02A61P37/06C12N5/0783
CPCA61K47/665A61K47/593A61K47/6927A61K47/02A61K39/3955A61P35/00A61P37/06A61P37/02C12N5/0636C12N2501/51C12N2501/515
Inventor 马洁张彤袁伟
Owner CANCER INST & HOSPITAL CHINESE ACADEMY OF MEDICAL SCI